BrightInsight Adds Biopharma Technology and Digital Health Expert, Karl Hick, to Advisory Council
May 17, 2022 08:00 ET
|
BrightInsight
SAN JOSE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the...
Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients
May 09, 2022 20:46 ET
|
Blue Note Therapeutics, Inc.
SAN FRANCISCO, May 09, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics and Bixink Therapeutics, a bio-subsidiary of KPS, today announced that the companies have entered into an exclusive licensing...
Serenity DTx Therapeutic Virtual Reality Comes to BC Interior
March 31, 2022 15:00 ET
|
Serenity DTx Inc.
CALGARY, Alberta, March 31, 2022 (GLOBE NEWSWIRE) -- Serenity DTx, a trusted provider of transformative digital therapeutics to measurably enhance and improve health and personal well-being, teamed...
Global Digital therapeutics Market to Perceive Noteworthy Growth Due to Growing Cases of Chronic Disorders Worldwide [175-Pages] | Divulge by Research Dive
March 21, 2022 09:03 ET
|
Research Dive
New York, USA, March 21, 2022 (GLOBE NEWSWIRE) -- A new report on the global digital therapeutics market has been added by Research Dive to its repository. As per the report, the market is expected...
Global Continuous Glucose Monitoring Devices (CGM) Market to Hit USD 13.24 Billion by 2028; Continuous Glucose Monitoring Devices Industry CAGR of 10.8% between 2022-2028; Exclusive Insight Report by Vantage Market Research
March 08, 2022 03:12 ET
|
Vantage Market Research
WASHINGTON, March 08, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Continuous Glucose Monitoring Devices Market finds that rising incidence of diabetes is...
By 2028, Global Demand for Digital Therapeutics Market Will Surpass USD 14.52 Billion at 28.1% CAGR Growth: Says Vantage Market Research
February 28, 2022 04:00 ET
|
Vantage Market Research
WASHINGTON, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Digital Therapeutics Market finds that the increasing incidence of preventable chronic diseases...
iMetabolic Biopharma Corporation (iMBP) Teams With Amazon Web Services (AWS) Diagnostic Development Initiative
February 15, 2022 10:00 ET
|
iMetabolic Biopharma Corporation
TEMPE, Ariz., Feb. 15, 2022 (GLOBE NEWSWIRE) -- iMetabolic Biopharma Corporation (iMBP) announces it has teamed with Amazon Web Services (AWS) to aid in the development of its proprietary iPlatform™...
Blue Note Therapeutics Enters Licensing Agreement With University of Sydney for ConquerFear, a Cancer Survivorship Intervention
February 03, 2022 09:00 ET
|
Blue Note Therapeutics
SAN FRANCISCO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics, a prescription digital therapeutics company dedicated to easing the burden of cancer and improving outcomes, today announced...
Blue Note Therapeutics Receives Breakthrough Device Designation for Prescription-Only Digital Therapeutic for Acute Myeloid Leukemia
January 06, 2022 16:02 ET
|
Blue Note Therapeutics
SAN FRANCISCO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics, a prescription digital therapeutics company dedicated to easing the burden of cancer and improving outcomes, today announced...
atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression
September 09, 2021 16:30 ET
|
atai Life Sciences
BERLIN and SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health...